Pharmaceutical company AstraZeneca has established a Science and Technology Integration Office to create partnerships with business, universities, governments and charities, the Daily Telegraph reported on 15 January.
The move is an effort to drive down the costs of developing new medicines.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.